Compass Therapeutics, Inc. financial data

Symbol
CMPX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
80 Guest Street, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Olivia Ventures, Inc. (to 6/8/2020)
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.19K % +22.1%
Debt-to-equity 6.97 % +8.4%
Return On Equity -34.9 % -33.7%
Return On Assets -32.6 % -33%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 138M shares +0.5%
Common Stock, Shares, Outstanding 138M shares +7.95%
Entity Public Float 98M USD -65.4%
Common Stock, Value, Issued 14K USD +7.69%
Weighted Average Number of Shares Outstanding, Basic 137M shares +8.15%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 15.1M USD +23.6%
Operating Income (Loss) -56.6M USD -12.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -47.2M USD -10.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -49.4M USD -16.2%
Earnings Per Share, Basic -0.36 USD/shares -9.09%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 43.5M USD +79.5%
Marketable Securities, Current 83.2M USD -35.1%
Cash, Cash Equivalents, and Short-term Investments 175M USD
Assets, Current 133M USD -13.7%
Property, Plant and Equipment, Net 353K USD -60.7%
Operating Lease, Right-of-Use Asset 6.73M USD +279%
Other Assets, Noncurrent 568K USD +77.5%
Assets 140M USD -10.5%
Accounts Payable, Current 2.25M USD -45%
Accrued Liabilities, Current 6.29M USD +150%
Liabilities, Current 8.87M USD +13.8%
Operating Lease, Liability, Noncurrent 6.3M USD +1075%
Liabilities 15.2M USD +82%
Accumulated Other Comprehensive Income (Loss), Net of Tax 210K USD +468%
Retained Earnings (Accumulated Deficit) -365M USD -15.7%
Stockholders' Equity Attributable to Parent 125M USD -15.7%
Liabilities and Equity 140M USD -10.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.9M USD -13.6%
Net Cash Provided by (Used in) Financing Activities 17.4M USD +42420%
Net Cash Provided by (Used in) Investing Activities -4.1M USD -196%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 138M shares +7.95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -554K USD +93%
Deferred Tax Assets, Gross 61.4M USD +38.7%
Operating Lease, Liability 6.63M USD +283%
Depreciation 200K USD 0%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -49.2M USD -16.7%
Lessee, Operating Lease, Liability, to be Paid 8.22M USD +355%
Property, Plant and Equipment, Gross 6.71M USD -6.29%
Operating Lease, Liability, Current 338K USD -71.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.02M USD +87.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 733K USD -42%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.58M USD +2041%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.41M USD
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.44M USD
Operating Lease, Payments 1.3M USD 0%
Deferred Tax Assets, Net of Valuation Allowance 1.9M USD +291%
Share-based Payment Arrangement, Expense 8.56M USD +39.9%